A new approach to restore lung function and reduce antibiotic resistance Read More

Disrupting bacterial biofilms and mucus to alter the progression of pulmonary diseases

View our Pipeline

Developing a new class of
glycopolymer-based therapeutics
that target key drivers
of pulmonary decline Read More

News

August 09, 2018

Synspira’s PAAG Therapy Demonstrates Persistence Against Pseudomonas aeruginosa Persister Cells

 Results published in Frontiers in Microbiology-Antimicrobials, Resistance and Chemotherapy 

Read More

A breath of fresh air in the treatment of lung disease.